Shilpa Medicare announces positive outcome of Phase 3 studies of NorUDCA
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Subscribe To Our Newsletter & Stay Updated